Back to Search
Start Over
Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.
- Source :
-
Mediterranean journal of hematology and infectious diseases [Mediterr J Hematol Infect Dis] 2018 Jan 01; Vol. 10 (1), pp. e2018011. Date of Electronic Publication: 2018 Jan 01 (Print Publication: 2018). - Publication Year :
- 2018
-
Abstract
- The heavy chain diseases (HCDs) are rare B-cell malignancies characterized by the production of a monoclonal immunoglobulin heavy chain without an associated light chain. There are three types of HCD, defined by the class of immunoglobulin heavy chain produced: IgA (α-HCD), IgG (γ-HCD), and IgM (μ-HCD). Alpha-HCD is the most common and usually occurs as intestinal malabsorption in a young adult from a country of the Mediterranean area. Gamma- and μ-HCDs are rarer and associated with a B-cell non-Hodgkin lymphoma that produces an abnormal Ig heavy chain. These patients may occasionally be diagnosed with a monoclonal gammopathy of undetermined significance (MGUS). Fanconi syndrome, on the other hand, can be primary (inherited) or secondary (acquired). The only exception to this rule is the idiopathic form. Adult acquired Fanconi syndrome can be a rare complication of a monoclonal gammopathy. At diagnosis, most patients have an MGUS or smoldering multiple myeloma, with renal failure and evidence of osteomalacia. During follow-up, patients can develop an end-stage renal disease. Chemotherapy provides little benefit on renal function.<br />Competing Interests: Competing interests: The authors have declared that no competing interests exist.
Details
- Language :
- English
- ISSN :
- 2035-3006
- Volume :
- 10
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Mediterranean journal of hematology and infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 29326807
- Full Text :
- https://doi.org/10.4084/MJHID.2018.011